HomeCURX • NASDAQ
add
Curanex Pharmaceuticals Inc
Previous close
$0.68
Day range
$0.65 - $0.69
Year range
$0.63 - $9.18
Market cap
19.10M USD
Avg Volume
3.06M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 57.66K | 30.45% |
Net income | -60.35K | -36.53% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 108.86K | -70.91% |
Total assets | 787.17K | 9.97% |
Total liabilities | 481.74K | 80,056.91% |
Total equity | 305.43K | — |
Shares outstanding | 27.75M | — |
Price to book | 67.60 | — |
Return on assets | -18.31% | — |
Return on capital | -20.04% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -60.35K | -36.53% |
Cash from operations | -290.08K | -22.75% |
Cash from investing | — | — |
Cash from financing | 200.00K | -65.52% |
Net change in cash | -90.08K | -126.20% |
Free cash flow | -252.98K | — |
About
Founded
1996
Website
